1. "Behavioral Sciences Service"
Formats
  1. Journal Article (729)
  2. Meeting Abstract (327)
  3. Book Section (40)
  4. Review (22)
  5. Editorial (21)
  6. Research Letter (8)
  7. Conference Paper (7)
  8. Correspondence (5)
  9. Book Whole (3)
  10. Guidelines (2)
Groups
  1. Behavioral Sciences Service (1164)
  2. Psychiatry and Behavioral Sciences, Department of (1164)
  3. Population Sciences Research Program (1015)
  4. Survivorship Research (714)
  5. Department of Medicine (323)
  6. Epidemiology and Biostatistics (308)

More Groups

People
  1. Jamie Ostroff (344)
  2. Jennifer Hay (265)
  3. Yuelin Li (219)
  4. Thomas Atkinson (155)
  5. Smita Banerjee (123)
  6. Jada Hamilton (111)

More People

Years
  1. 2025 (24)
  2. 2024 (56)
  3. 2023 (93)
  4. 2022 (82)
  5. 2021 (94)
  6. 2020 (69)

More Years

Publications
  1. Annals of Behavioral Medicine (138)
  2. Journal of Clinical Oncology (87)
  3. Psycho-Oncology (74)
  4. Quality of Life Research (37)
  5. Cancer (33)
  6. Supportive Care in Cancer (21)

More Publications

Publishers
  1. Springer (273)
  2. American Society of Clinical Oncology (115)
  3. Elsevier Inc. (88)
  4. John Wiley & Sons (83)
  5. Oxford University Press (53)
  6. Wiley Blackwell (49)

More Publishers

Results (1164)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study
    Meeting Abstract

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C. T.; Dickler, M. N.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Validation study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Meeting Abstract

    Dueck, A. C.; Mendoza, T. R.; Reeve, B. B.; Sloan, J. A.; Cleeland, C. S.; Hay, J.; Li, Y.; O'Mara, A. M.; Denicoff, A.; Basch, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The development and implementation of an institution-based communication skills training program for oncologists
    Meeting Abstract

    Bialer, P. A.; Gilewski, T.; Kissane, D.; Levin, T.; Dickler, M. N.; Park, B. J.; Bylund, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)
    Meeting Abstract

    Atkinson, T. M.; Sit, L.; Mendoza, T. R.; Fruscione, M.; Lavene, D.; Shaw, M.; Breitbart, W.; Rosenfeld, B.; Cleeland, C. S.; Basch, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • The integrated model of intercultural communication competence (IMICC): Model test
    Journal Article

    Arasaratnam, L.; Banerjee, S.; Dembek, K.
    Australian Journal of Communication (2010)

    Fulltext@MSK | Save
  • Sun exposure and cancer risk
    Book Section

    Berwick, M.; Hay, J.
    In Holland, J. C.; Breitbart, W. S.; Jacobsen, P. B.; Lederberg, M. S.; Loscalzo, M. J.; MccorKle, R. S. (Eds.) Psycho-Oncology. 2nd ed (2010)

    Fulltext@MSK | Save
  • Impact of treatment for depression on desire for hastened death in patients with advanced AIDS
    Journal Article

    Breitbart, W.; Rosenfeld, B.; Gibson, C.; Kramer, M.; Li, Y.; Tomarken, A.; Nelson, C.; Pessin, H.; Esch, J.; Galietta, M.; more...
    Psychosomatics (2010)

    Fulltext@MSK | Save
  • Clinically meaningful change in erectile function domain scores
    Meeting Abstract

    Nelson, C.; Balk, E.; Narus, J.; Atkinson, T.; Mulhall, J.
    Journal of Sexual Medicine (2010)

    Fulltext@MSK | Save
  • STRIDE: Phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer
    Meeting Abstract

    Eiermann, W.; Miles, D.; Gilewski, T.; Trudeau, M.; Xu, B.; Barrios, C.; Pendergrass, K.; Eggleton, S. P.; Kashala, O.; Shulman, L.
    EJC Supplements (2010)

    Fulltext@MSK | Save